A61P 35 - Antineoplastic agents

Patents for A61P 35 - Antineoplastic agents (221,099)
10/2002
10/09/2002	CN1373768A Oligonucleotide N3'-P5' thiophosphoramidates, their synthesis and use
10/09/2002	CN1373763A Pteridinones and kinase inhibitors
10/09/2002	CN1373762A Phenanthroline-7-one derivs. and their therapeutic applications
10/09/2002	CN1373761A Phenanthroline-7-one derivs. and their therapeutic uses
10/09/2002	CN1373757A Heterocyclically substd, benzoylguanidine, method for production thereof, use thereof as medicament or means of diagnosis and medicaments contg. same
10/09/2002	CN1373751A 'Alpha'-amino-'beta'-sulfonyl hydroxamic acid compounds
10/09/2002	CN1373671A Treatment of patients having non-hodgkins lymphoma with bone marrow involvement with anti-CD20 antibodies
10/09/2002	CN1373668A Hybrid peptide modulate immune response
10/09/2002	CN1373667A Formulations for parenteral use of estramustine phosphate and amino acids
10/09/2002	CN1373666A Medicament with protective effect against oxidative-toxic substances, particularly against cardiotoxin substances
10/09/2002	CN1373662A 3(5)-amino-pyrazole derivs., process for their preparation and their use as antitumor agents
10/09/2002	CN1373209A High-yield bacterial strain C-1027-20 for preparing Lidamycin as antineoplastic antibiotic
10/09/2002	CN1373126A Crystallization formed N-(4-trifluoromethylphenyl)-5-methyl isooxazo-4-carboxamide
10/09/2002	CN1372971A Chinese-medicinal injection for treating cancer
10/09/2002	CN1372948A Exterior-applied liquid medicine for promoting blood circulation, dispelling exogenous factor of wind and relaxing pain
10/09/2002	CN1372936A Antineoplastic
10/09/2002	CN1372929A Application of N-acetyl-D-aminoglucose in preparing medicines to suppress by-effect of radiotherapy and chemicotherapy
10/09/2002	CN1372927A Application of phenazinone derivative in preparing antineoplastic and tumor transfer-resistant medicines
10/09/2002	CN1372926A Medicinal ointment containing zinc conjugated linoleate and sodium humate
10/09/2002	CN1092204C Semisynthesizing method for 20(S)-ginsenoside Rg3, and use thereof in medicine
10/09/2002	CN1092185C Dihydrodibenzo isoquinolines diketone, its pharmaceutical composition and use, and method for preparing same
10/09/2002	CN1092055C Chinese medicine preparation
10/09/2002	CN1092053C Process for preparing active aloe powder
10/09/2002	CN1092047C Chemical compound for treating cancer and preparing process thereof
10/08/2002	US6462208 C7 acyloxy and hydrido taxane derivatives and pharmaceutical compositions containing them
10/08/2002	US6462196 Preparation of a camptothecin derivative by intramolecular cyclization
10/08/2002	US6462173 Inhibitors of phosphoserine and phosphothreonine-proline-specific isomerases
10/08/2002	US6462087 Anti-tumor composition
10/08/2002	US6462076 Beta-amino acid nitrile derivatives as cathepsin K inhibitors
10/08/2002	US6462075 Chalcone and its analogs as agents for the inhibition of angiogensis and related disease states
10/08/2002	US6462069 Kinase inhibitors; anticancer agents
10/08/2002	US6462065 Use of 5-HT3 receptor antagonists for treating musculoeskeletal diseases
10/08/2002	US6462064 Apoptosis inducing adamantyl derivatives and their usage as anti-cancer agents, especially for cervical cancers and dysplasias
10/08/2002	US6462060 Heterocyclic-hydroxyimino-fluorene nuclei compounds and pharmaceutical compositions for inhibiting protein kinases, and methods for their use
10/08/2002	US6462047 Containing 5- or 6-membered oxygen, nitrogen and/or sulfur heteroaryl group; angina, hypertension, respiratory distress, congestive heart failure, renal failure, atherosclerosis, inflammatory diseases, strokes, bronchitis, asthma
10/08/2002	US6462038 Such as 1,2,3,6-tetrahydro-1-methyl-9-(trifluoromethyl)-7h-(1,4)oxazino(3,2 -g)quinolin-7-one; nonsteroidal, high affinity and specificity antagonists and agonists or partial agonists, i.e. partial and/or tissue specific activators
10/08/2002	US6462036 Inhibiting signal transduction by modulating activity of receptor and nonreceptor tyrosine and serine/threonine kinases to regulate and modulate abnormal or inappropriate cell proliferation, differentiation, or metabolism
10/08/2002	US6462017 Method of reducing side effects of chemotherapy in cancer patients
10/08/2002	US6461867 Synthetic antigen presenting matrix
10/08/2002	US6461855 Microtubule stimulated atpase activity; cancer and nervous system disorder diagnosis
10/08/2002	US6461848 Degrades heparin sulfate preventing deposits of beta-amyloid senile plaques
10/08/2002	US6461846 Peptide for use in the treatment of alzhiemer's, inflammation, cancer and immune defects
10/08/2002	US6461641 Adding to bioactive agent polymeric vehicle which gels or solidifies at time of or shortly after injection and has consistency and density to displace cells and to retain bioactive agent at injection site, thereby enhancing delivery
10/08/2002	US6461602 Water-soluble, nontoxic prodrugs having a hydrolyzable carbamate group coupling the drug or active ingredient to a modified polymer; insoluble drug released in vivo; drug delivery
10/08/2002	CA2252982C Substituted indazole derivatives and their use as inhibitors phosphodiesterase (pde) type iv and the production of tumor necrosis factor (tnf)
10/08/2002	CA2220995C New derivatives of substituted 7,12-dioxa-benzo¬a\|anthracenes, their preparation process and the pharmaceutical compositions they contain
10/08/2002	CA2066083C Benzodiazepine analogs as cholecystokinin antagonists
10/04/2002	CA2342708A1 Methods for inhibiting cancer growth, reducing infection and promoting general health with a fermented soy extract
10/03/2002	WO2002077267A2 Nucleic acid molecules encoding a transmembran serine protease 9, the encoded polypeptides and methods based thereon
10/03/2002	WO2002077266A2 Novel fibroblast growth factor and nucleic acids encoding same
10/03/2002	WO2002077263A2 Nucleic acid molecules encoding serine protease cvsp14, the encoded polypeptides and methods based thereon
10/03/2002	WO2002077255A1 Topoisomerase i selective cytotoxic sugar derivatives of indolopyrrolocarbazoles
10/03/2002	WO2002077236A2 Compositions and methods relating to lung specific genes and proteins
10/03/2002	WO2002077232A2 Compositions and methods relating to breast specific genes and proteins
10/03/2002	WO2002077217A2 Human dual specificity protein phosphatase 7-like protein
10/03/2002	WO2002077184A2 Oligonucleotide conjugates
10/03/2002	WO2002077033A1 Antibodies against cancer
10/03/2002	WO2002077029A2 Cd19-specific redirected immune cells
10/03/2002	WO2002077027A1 Human stra6-like protein and nucleic acids encoding the same
10/03/2002	WO2002077023A2 A new essential downstream component of the wingless signalling pathway
10/03/2002	WO2002077017A2 Medical uses of intercellular communication facilitating compounds
10/03/2002	WO2002077003A1 Process for obtaining lignan, pharmaceutical compositions and uses thereof
10/03/2002	WO2002076994A1 Tumor-inhibiting silicon compounds
10/03/2002	WO2002076989A1 Protein phosphate inhibitors
10/03/2002	WO2002076986A1 Pyrazolopyrimidines as therapeutic agents
10/03/2002	WO2002076979A1 1,2,3,4-tetrahydroisoquinolines derivatives as urotensin ii receptor antagonists
10/03/2002	WO2002076977A2 Rho-kinase inhibitors
10/03/2002	WO2002076976A2 Rho-kinase inhibitors
10/03/2002	WO2002076975A1 Chemical derivatives and their use as anti-telomerase agent
10/03/2002	WO2002076965A1 Non peptide mimetics based on the active sequence s42fllr46 of the thrombin receptor for the treatment of thrombosis and cancer
10/03/2002	WO2002076957A1 Activator for peroxisome proliferator-activated receptor
10/03/2002	WO2002076953A1 New spirotricyclic derivatives and their use as phosphodiesterase-7 inhibitors
10/03/2002	WO2002076951A1 2-mercapto-4,5-diarylimidazole derivatives and the use thereof as cyclooxygenase inhibitors
10/03/2002	WO2002076948A1 Novel piperidine derivatives as modulators of chemokine receptors
10/03/2002	WO2002076946A2 Fused pyridine derivatives for use as vanilloid receptor antagonists for treating pain.
10/03/2002	WO2002076939A2 Cysteine protease inhibitors
10/03/2002	WO2002076930A2 Substituted diarylureas as stimulators for fas-mediated apoptosis
10/03/2002	WO2002076548A2 Methods and apparatus for treating diseased tissue
10/03/2002	WO2002076510A1 Use of biomolecular targets in the treatment and visualization of brain tumors
10/03/2002	WO2002076509A2 Preparation for the prophylaxis of restenosis
10/03/2002	WO2002076500A1 Vaccine for the treatment of tubercolosis and other intracellular infections diseases
10/03/2002	WO2002076499A2 Combination treatment of pancreatic cancer
10/03/2002	WO2002076497A2 Method and composition
10/03/2002	WO2002076491A1 Liposome targeting of matrix metalloproteinase inhibitors
10/03/2002	WO2002076486A2 Histidine-rich glycoprotein
10/03/2002	WO2002076484A2 Combination of a taxane and a cyclin-dependent kinase inhibitor
10/03/2002	WO2002076476A2 Prodrugs of anticancer agents employing substituted aromatic acids
10/03/2002	WO2002076474A1 Co-administration of a polysaccharide with a chemotherapeutic agent for the treatment of cancer
10/03/2002	WO2002076472A2 Pharmaceutical combinations for the treatment of cancer comprising dioxolane nucleoside analogs
10/03/2002	WO2002076468A1 Tumor therapy with alphavirus-based and high affinity laminin receptor-targeted vectors
10/03/2002	WO2002076459A1 Method and dosage form for treating tumors by the administration of tegafur, uracil, folinic acid, paclitaxel and carboplatin
10/03/2002	WO2002076457A1 Novel amides, preparation and therapeutic use as modulators of ccr-receptor activity
10/03/2002	WO2002076454A1 Method for treatment of cancer and compositions for use therein
10/03/2002	WO2002076451A1 Use of certain substituted pyrrolidones such as piracetam in the treatment of viral and other diseases
10/03/2002	WO2002076450A1 Dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
10/03/2002	WO2002076448A1 Molecular conjugates for use in treatment of cancer
10/03/2002	WO2002076439A2 Compounds capable of modulating the activity of multidrug transporters and therapeutic use of the same
10/03/2002	WO2002076438A2 Flt-1 ligands and their uses in the treatment of diseases regulatable by angiogenesis
10/03/2002	WO2002076404A2 Fatty alcohol drug conjugates
10/03/2002	WO2002076402A2 Fatty amine drug conjugates

1 ... 1655 1656 1657 1658 1659 1660 1661 1662 1663 1664 1665 1666 1667 1668 1669 1670 1671 1672 1673 1674 1675 ... 2211